Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human CD63 Antibody, R&D Systems™

Rabbit Monoclonal Antibody
Supplier: R&D Systems MAB50482SP
This item is not returnable.
View return policy
Description
CD63 Monoclonal specifically detects CD63 in Human samples. It is validated for Western Blot, Simple Western, Immunohistochemistry, Intracellular Staining by Flow Cytometry, CyTOF-ready.Specifications
CD63 | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. | |
CD63, CD63 antigen, CD63 antigen (melanoma 1 antigen), CD63 molecule, Granulophysin, Lamp-3, Lysosomal-associated membrane protein 3, ME491, melanoma 1 antigen, Melanoma-associated antigen ME491, melanoma-associated antigen MLA1, MLA1lysosome-associated membrane glycoprotein 3, Ocular melanoma-associated antigen, OMA81H, Tetraspanin-30, tspan-30, Tspan30, TSPAN30granulophysin | |
Chinese Hamster Ovary cell line CHO-derived human CD63, Ala103-Val203, Accession # P08962-1 | |
25 μg | |
Primary | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution. | |
IgG |
Western Blot, Immunohistochemistry, Flow Cytometry, CyTOF | |
2585J | |
Western Blot 0.5 ug/mL, Simple Western 20 ug/mL, Immunohistochemistry 0.3-25 ug/mL, Intracellular Staining by Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready | |
P08962-1 | |
Rabbit | |
Protein A or G purified from cell culture supernatant | |
RUO | |
967 | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction